Effects of large dosage atorvastatin on serum metalloproteinases in patients with acute coronary syndrom
Yiya Zhang
Abstract
Yiya Zhang
Abstract
Objective:To evaluated the effect of different dosage atorvastatin on serom metalloproteinases(MMP),C-reactive protein(CRP) and lipids in patiente with acute coronary syndrom(ACS) as well as its safty.Methods:46 patients with ACS were randomized to receive atorvastatin(20 mg/d,goup 1) or(40-60 mg/d,group 2) after admition.Serom lipids,CRP and MMP were assessed at baseline,1week and 4 weeks after treatment.Results:1.Compared to baseline,the levels of total cholesterol(TC),LDL-C were significantly reduced after 1 week(P0.05) and 4 weeks(P0.01) in group 2.2.MMP-2,MMP-9 and CRP significantly decreased at 1 week(P0.05)and 4 weeks(P0.01) compared to baseline in two group,But compared to that of group 1,there is more obviously decrease in group 2.3.AST,renal function and creatine kinase remained unchanged after therapy.Conclusion:Large dosage atorvastatin(40-60mg) therapy early is superior to atorvastatin(20mg) in decreasd serom lipids,anti-inflammation and stablised lipide lesion.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluated the effect of different dosage atorvastatin on serom metalloproteinases(MMP),C-reactive protein(CRP) and lipids in patiente with acute coronary syndrom(ACS) as well as its safty.Methods:46 patients with ACS were randomized to receive atorvastatin(20 mg/d,goup 1) or(40-60 mg/d,group 2) after admition.Serom lipids,CRP and MMP were assessed at baseline,1week and 4 weeks after treatment.Results:1.Compared to baseline,the levels of total cholesterol(TC),LDL-C were significantly reduced after 1 week(P0.05) and 4 weeks(P0.01) in group 2.2.MMP-2,MMP-9 and CRP significantly decreased at 1 week(P0.05)and 4 weeks(P0.01) compared to baseline in two group,But compared to that of group 1,there is more obviously decrease in group 2.3.AST,renal function and creatine kinase remained unchanged after therapy.Conclusion:Large dosage atorvastatin(40-60mg) therapy early is superior to atorvastatin(20mg) in decreasd serom lipids,anti-inflammation and stablised lipide lesion.
Key concepts: Atorvastatin, Medicine, Creatine, Internal medicine, C-reactive protein, Creatine kinase, Matrix metalloproteinase, Gastroenterology